Great Point Partners as of March 31, 2022
Portfolio Holdings for Great Point Partners
Great Point Partners holds 30 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Exelixis (EXEL) | 7.1 | $30M | 1.3M | 22.67 | |
| Xenon Pharmaceuticals (XENE) | 6.8 | $28M | 920k | 30.57 | |
| Travere Therapeutics (TVTX) | 6.3 | $26M | 1.0M | 25.77 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.8 | $24M | 551k | 43.88 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.8 | $24M | 155k | 155.67 | |
| Cytokinetics Com New (CYTK) | 5.8 | $24M | 650k | 36.81 | |
| Chinook Therapeutics | 5.6 | $23M | 1.4M | 16.36 | |
| Galapagos Nv Spon Adr (GLPG) | 5.4 | $22M | 360k | 62.02 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.4 | $22M | 85k | 260.96 | |
| Vaxcyte (PCVX) | 5.2 | $21M | 885k | 24.15 | |
| Relmada Therapeutics (RLMD) | 5.2 | $21M | 790k | 26.99 | |
| Anaptysbio Inc Common (ANAB) | 4.2 | $17M | 700k | 24.74 | |
| Point Biopharma Global | 4.0 | $16M | 2.1M | 7.97 | |
| Aclaris Therapeutics (ACRS) | 3.9 | $16M | 942k | 17.24 | |
| Kalvista Pharmaceuticals (KALV) | 3.1 | $13M | 874k | 14.74 | |
| Rigel Pharmaceuticals Com New (RIGL) | 2.9 | $12M | 4.0M | 2.99 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 2.7 | $11M | 1.1M | 9.94 | |
| Tricida | 2.5 | $10M | 1.3M | 8.22 | |
| Avidity Biosciences Ord (RNA) | 2.2 | $9.2M | 500k | 18.47 | |
| Silence Therapeutics Ads (SLN) | 2.0 | $8.4M | 444k | 19.00 | |
| Urogen Pharma (URGN) | 1.8 | $7.6M | 873k | 8.71 | |
| Pieris Pharmaceuticals (PIRS) | 1.6 | $6.7M | 2.2M | 3.03 | |
| Ardelyx (ARDX) | 1.2 | $5.1M | 4.8M | 1.07 | |
| Ventyx Biosciences (VTYX) | 1.1 | $4.6M | 336k | 13.57 | |
| Acumen Pharmaceuticals (ABOS) | 0.9 | $3.6M | 928k | 3.91 | |
| Magenta Therapeutics | 0.8 | $3.4M | 1.2M | 2.90 | |
| Cincor Pharma | 0.3 | $1.4M | 80k | 17.53 | |
| Nektar Therapeutics Call Option (NKTR) | 0.1 | $539k | 100k | 5.39 | |
| Passage Bio (PASG) | 0.1 | $353k | 114k | 3.10 | |
| Rafael Hldgs Com Cl B (RFL) | 0.1 | $304k | 121k | 2.51 |
